| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Sweden | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | United States | 2 | |
| #7 | China | 1 | |
| #8 | India | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hellman Lars | 21 |
| #2 | Olsson Anna-Karin | 7 |
| #3 | Anna-Karin Olsson | 2 |
| #4 | Lars Hellman | 2 |
| #5 | Saupe Falk | 1 |
| #6 | Falk Saupe | 1 |
| Publication | Filing date | Title |
|---|---|---|
| SE1500434A1 | A novel fusion partner for highly efficient and safe vaccines | |
| SE0901565A1 | A new vaccine that attacks tumor vessels as an effective tool in tumor therapy | |
| WO2008066443A1 | Il-33 vaccine for the treatment of inflammatory conditions with a strong th2 component | |
| US2010021486A1 | Tslp vaccine for the treatment of th2 mediated inflammatory conditions | |
| EP2091562A1 | Il- 18 vaccine for the treatment of various inflammatory conditions. |